Chromosome 9 Deletion in Ovarian Cancer
Author Information
Author(s): J Devlin, PA Elder, H Gabra, CM Steel, MA Knowles
Primary Institution: Marie Curie Research Institute
Hypothesis
The study aims to assess the frequency of deletion on both arms of chromosome 9 in ovarian tumors and localize potential tumor-suppressor genes.
Conclusion
The study found that deletions of both 9p and 9q occurred at high frequency in ovarian tumors, with 79% showing loss of heterozygosity.
Supporting Evidence
- 79% of the ovarian tumors showed loss of heterozygosity.
- 33% of tumors had loss of all informative markers.
- 70% of tumors had deletions on chromosome 9p.
Takeaway
Researchers looked at 33 ovarian tumors and found that many had missing pieces on chromosome 9, which might be important for understanding cancer.
Methodology
The study screened ovarian tumor samples for loss of heterozygosity using microsatellite markers and performed deletion mapping.
Limitations
The study may underestimate the frequency of homozygous deletion of CDKN2 since not all tumors were critically evaluated by quantitative PCR.
Want to read the original?
Access the complete publication on the publisher's website